Safe to stop aspirin three months post-stent: study
No need for patients to be on dual antiplatelet therapy for a year, US reserachers say
After receiving a stent, patients on dual antiplatelet therapy can drop aspirin after three months without increasing their risk of death, a South Korean trial suggests.
The mortality rate in patients who stopped aspirin after three months and continued with a P2Y12 inhibitor alone was similar (2.9% versus 2.5%) to that of patients who remained on dual therapy for one year, according to data from nearly 3000 patients in the SMART-CHOICE trial.
